2010_宫颈癌.pdf
2010_宫颈癌.pdf
Copyright © National Comprehensive Cancer Network 2010. All rights reserved. “NCCN”, the NCCN logo, and “National Comprehensive Cancer Network” are
registered trademarks of the National Comprehensive Cancer Network.
The Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Cervical Cancer Guideline 2010 is the Chinese adapted version of NCCN Clinical Practice
Guidelines in Oncology-Cervical Cancer Guideline, V.1.2010 as permitted and endorsed by NCCN. It is the collaborative outcome of the National Comprehensive
Cancer Network and Chinese key opinion leaders of the field.
The original guideline and Chinese edition are both available at: http://www.nccn.org. To view the most recent and complete version of the guideline, go online to
www.nccn.org. These Guidelines and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the NCCN.
These Guidelines are a work in progress that will be refined as often as new significant data becomes available. The NCCN Guidelines are a statement of consensus
of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult any NCCN guideline is expected to use
independent medical judgment in the context of individual clinical circumstance to determine any patient's care or treatment. The National Comprehensive Cancer
Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
This publication should not be used for commercial purpose. It is provided for free to Chinese medical professions with the support of the unrestrictive educational
grant of GlaxoSmithKline (China) Investment Co. Ltd. which exerts no influence to the formation of the Chinese edition of NCCN Clinical Practice Guidelines in
Oncology-Cervical Cancer Guideline 2010.
NCCN ® 肿瘤学临床实践指南(中国版)2010年 第一版
© National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.
The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive
Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org.
宫颈癌
NCCN宫颈癌专家组成员
妇科肿瘤
肿瘤内科
血液科
放疗科/放射肿瘤科
病理科
编委会成员
Ω
†
‡
§
≠
*
* Benjamin E.Greer, MD/Co-Chair Ω
Fred Hutchinson Cancer Research
Center/Seattle Cancer Care Alliance
* Wui-Jin Koh, MD/Co-Chair §
Fred Hutchinson Cancer Research
Center/Seattle Cancer Care Alliance
Nadeem R. Abu-Rustum, MD Ω
Memorial Sloan-Kettering Cancer Center
Sachin M. Apte, MD, MS Ω
H. Lee Moffitt Cancer Center & Research
Institute
Michael A. Bookman, MD †
Fox Chase Cancer Center
Robert E. Bristow, MD Ω
The Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins
Susana M. Campos, MD, Mph, MS †
Dana-Farber / Brigham and Women′s
Cancer Center
John Chan, MD Ω
UCSF Helen Diller Family Comprehensive
Cancer Center
Kathleen R. Cho, MD ≠
University of Michigan
Comprehensive Cancer Center
Larry Copeland, MD Ω
The Ohio State University Comprehensive
Cancer Center - James Cancer Hospital
and Solove Research Institute
Marta Ann Crispens, MD Ω
Vanderbilt-Ingram Cancer Center
Nefertiti duPont, MD, MPH Ω
Roswell Park Cancer Institute
Patricia J. Eifel, MD §
The University of Texas
M. D. Anderson Cancer Center
Warner K. Huh, MD Ω
University of Alabama at Birmingham
Comprehensive Cancer Center
Daniel S. Kapp, MD, PhD §
Stanford Comprehensive Cancer Center
John R. Lurain, III MD Ω
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University
Mark A. Morgan, MD Ω
Fox Chase Cancer Center
Robert J. Morgan, Jr., MD † ‡
City of Hope Comprehewsive
Cancer Center
Steven W. Remmenga, MD Ω
UNMC Eppley Cancer Center at
The Nebraska Medical Center
R. Kevin Reynolds, MD Ω
University of Michigan
Comprehensive Cancer Center
Angeles Alvarez Secord, MD Ω
Duke Comprehensive Cancer Center
William Small, Jr., MD §
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University
Nelson Teng, MD, PhD Ω
Stanford Comprehensive Cancer Center
NCCN ®宫颈癌 肿瘤学临床实践指南(中国版)2010年 第一版
© National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.
The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive
Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org.
NCCN特别鸣谢
NCCN指南中国版专家组
召集人：
孙 燕
中国医学科学院北京协和医学院
肿瘤医院
NCCN代表：
Robert J. Morgan, Jr., MD
City of Hope Comprehensive
Cancer Center
NCCN宫颈癌临床实践指南（中国版）专家组
组 长：
沈 铿
中国医学科学院北京协和医学院北京协和医院
成 员（按拼音排序）：
曹泽毅
清华大学第二附属医院
崔 恒
北京大学人民医院
狄 文
上海交通大学医学院附属仁济医院
丰有吉
复旦大学附属妇产科医院
高雨农
北京大学临床肿瘤学院、北京肿瘤医院
郭丽娜
中国医学科学院北京协和医学院北京协和医院
郝 权
天津医科大学附属肿瘤医院
孔北华
山东大学齐鲁医院
郎景和
中国医学科学院北京协和医学院北京协和医院
李 力
广西医科大学附属肿瘤医院
李子庭
复旦大学附属肿瘤医院
林仲秋
中山大学附属第二医院
执笔人：
吴小华
复旦大学附属肿瘤医院
刘继红
中山大学附属肿瘤医院
刘丽影
中国医学科学院北京协和医学院肿瘤医院
马 丁
华中科技大学同济医学院附属同济医院
盛修贵
山东省肿瘤医院
宋 磊
中国人民解放军总医院(三○一医院)
魏丽惠
北京大学人民医院
吴令英
中国医学科学院北京协和医学院肿瘤医院
吴 鸣
中国医学科学院北京协和医学院北京协和医院
吴 强
江苏省肿瘤医院
向 阳
中国医学科学院北京协和医学院北京协和医院
谢 幸
浙江大学医学院附属妇产科医院
张福泉
中国医学科学院北京协和医学院北京协和医院
NCCN ® 肿瘤学临床实践指南(中国版)2010年 第一版
© National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.
The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive
Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org.
宫颈癌
目录
NCCN宫颈癌专家组成员
NCCN特别鸣谢
指南更新概要
临床分期（CERV-1）
IA1期（CERV-2）
IA2、IB1期和IIA1期（CERV-2）
IB2和IIA2期（CERV-2）
部分巨块型IB2期、IIA2期和IIB、IIIA、IIIB、IVA期（CERV-4）
单纯子宫切除时意外发现的宫颈浸润癌（CERV-7）
监测（CERV-8）
局部/区域复发（CERV-9）
远处转移（CERV-10）
宫颈癌的化疗方案（CERV-A）
分期
讨论
参考文献
临床试验：NCCN认为任何肿瘤患者都可以在临床试验中得到最
佳处理，因此特别鼓励肿瘤患者参加临床试验研究。
NCCN对证据和共识的分类：
除非特别指出，NCCN对所有建议均达成2A类共识。
见NCCN对证据和共识的分类
NCCN宫颈癌指南包括了对宫颈鳞状细胞癌、宫颈腺鳞癌和宫颈腺癌的处理。
作为共识，NCCN肿瘤学临床实践指南反映了作者们对目前认可的治疗方法的观点，欲参考或应用这些指南的临床医师应根据个人具体的临床情况做出独立的医疗判断，以决定患者所需的护理和治
疗。任何寻求使用这些指南的患者或非医生人员应咨询医生关于它们的合理应用。
NCCN肿瘤学临床实践指南编译力求精确表达反映原版英文指南。NCCN不保证指南编译的有效性，也不承认任何无限制性的担保、表达及暗示。NCCN不担保指南编译或指南本身的精确性和完整
性。NCCN不保证或担保或陈述指南的应用及应用结果。NCCN及其成员不对涉及指南无限制性应用的任何偶然的、间接的、特殊的、惩罚性或作为结果的补偿费承担任何责任。
声明：
本指南中标注“※”处为中国专家根据国内实际情况进行明显
改动或补充之处，内容有别于英文版，参考时请注意。
...
